Autoimmune thyroid dysfunction after hematopoietic stem cell transplantation

Bone Marrow Transplant. 2005 Feb;35(4):383-8. doi: 10.1038/sj.bmt.1704766.


Autoimmune thyroid disease (AITD) may occur in patients after hematopoietic stem cell transplantation (HSCT). In all, 10 cases of AITD (seven allogeneic and three autologous HSCT) were diagnosed among 721 HSCT recipients, including two patients with sequential hyper- and hypothyroidism. The 5-year actuarial rates for AITD after allogeneic and autologous HSCT were 2.9 and 4%, respectively. Significant risk factors included HSCT for chronic myeloid leukemia, the HLA B46 and DR9 loci and the A2B46DR9 haplotype, while female donors showed trend to significance. On multivariate analysis, only female donors and HLA DR9 remained significant. For autologous HSCT, the associations with HLA B46 and DR9 were also significant. Only three donors had a family history of AITD. A review of other reported cases confirmed the predominance of female donors, although the other associations including graft-versus-host disease, familial AITD and other autoimmune phenomena might be related to reporting bias. Since the actuarial incidence of AITD from female donors with predisposing HLA alleles may be over 30%, susceptible recipients should be carefully monitored. Owing to the small number of reported cases and different HLA associations with AITD in different populations, our observations await confirmatory data from other registries.

MeSH terms

  • Adult
  • Case-Control Studies
  • Female
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Lymphoproliferative Disorders / therapy*
  • Male
  • Middle Aged
  • Thyroiditis, Autoimmune* / etiology
  • Transplantation, Autologous
  • Transplantation, Homologous